Search alternatives:
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 point » _ point (Expand Search)
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 point » _ point (Expand Search)
-
6121
-
6122
Biopsy.
Published 2025“…Increasing CD incidence was observed from 13.11 per 100.000 person/year in 2012 to 20.92 per 100.000 100.000 person/year in 2019 (95% CI = 6.8–15.5). …”
-
6123
CD diagnosis method.
Published 2025“…Increasing CD incidence was observed from 13.11 per 100.000 person/year in 2012 to 20.92 per 100.000 100.000 person/year in 2019 (95% CI = 6.8–15.5). …”
-
6124
S1 Graphical abstract -
Published 2024“…Over 2000–2019, the ASIRs for small intestine cancer among men and women were 2.61 (95% CI: 2.59–2.64) and 1.92 (95% CI: 1.89–1.94) per 100,000, indicating a significant increase of 2.01% and 2.12%, respectively. …”
-
6125
-
6126
-
6127
-
6128
LF4A-GFP localizes to the basal bodies and along cilia, is transported by IFT and affects IFT.
Published 2019“…<p>(A-B) A wild-type (negative control non-GFP expressing) cell (A) and a cell expressing LF4A-GFP under the native promoter (B) were subjected to simultaneous fixation/permeabilization (using a mixture of paraformaldehyde and Triton X-100) and stained with the anti-GFP antibodies (red) and DAPI (blue). …”
-
6129
-
6130
-
6131
-
6132
Pharmacodynamic Profile of CCX168 in Healthy Human Volunteers.
Published 2016“…(A) C5a-induced upregulation of CD11b on the surface of neutrophils in whole blood collected in the placebo group (●), and at 2 hours (♦) and 24 hours (◊) after a single dose of 10 mg CCX168, at 2 hours (▲) and 12 hours (Δ) after a single dose of 30 mg CCX168, and 2 hours (■) and 12 hours (□) after a single dose of 100 mg CCX168. …”
-
6133
Video 1_v1_Clinical application of endoscopic surgery using a gasless unilateral transaxillary approach in the treatment of primary hyperparathyroidism.mp4
Published 2022“…During a follow-up period of 3 to 36 months, a total of 1 patient in the open group experienced recurrence at 10 months after surgery and was treated non-surgically.…”
-
6134
-
6135
-
6136
-
6137
-
6138
-
6139
Combination treatments increased p53 and decreased c-Myc levels in U-87MG and U-251MG cells more than did single treatments.
Published 2019“…<p>A-C: Western blot data showed that SLCP+BBR increased p53 and decreased c-Myc levels significantly more in U-87MG and U-251MG cells, in comparison to single treatments. …”
-
6140